Written by: Zhang Weilun
Last update date: 2020-11-26 08:00
Alibaba Health (0241) announced its interim results as of the end of September this year. During the period, it turned from a loss to a profit and earned 278 million yuan (RMB ‧ the same below) without dividends.
Revenue was 7.162 billion yuan, an increase of 74% year-on-year; adjusted profit was 436 million yuan, an increase of 286.4% year-on-year.
The company pointed out that it achieved a turnaround during the period, and the number of users in a number of businesses has grown rapidly. It completed the acquisition of the pharmaceutical category e-commerce platform business from Ali JK Nutritional Products Holding Limited in April this year, and the rapid growth of pharmaceutical self-operated business income and gross profit , And efficiency improvement and cost optimization promoted by economies of scale.
Alibaba health profit alert expects to earn no less than 200 million RMB in the medium term
JD Health goes public | Who is more worth investing in the valuation of Ali Health and Ping An Good Doctor?
Ali Health is underweight by Ali?
Company: false news, please clarify the basic facts
Alibaba Health is rumored to raise more than 8 billion yuan by placing 400 million new shares
Alibaba health company performance